Evidence map›Paper›PMID 26499987›Full record

ReviewBMC infectious diseases2015

Rotavirus-associated mild encephalopathy with a reversible splenial lesion (MERS)-case report and review of the literature.

Konstantinos Karampatsas, Christina Spyridou, Ian R Morrison, Cheuk Y W Tong, Andrew J Prendergast

Open access · goldAbstract readCase ReportsReview
In one paragraph

Review in BMC infectious diseases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Splenial lesions of the corpus callosum: a comprehensive study on etiology, clinical presentation, radiological features, and prognostic insights.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Review
  5. Article
  6. Article
  7. Review
  8. A case of mild encephalitis associated with COVID-19.Journal of general and family medicine · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Observational
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Konstantinos KarampatsasDepartment of Paediatrics, The Royal London Hospital, Barts Health NHS Trust, London, UK. kostaskarab@gmail.com.
Christina SpyridouDepartment of Paediatrics, The Royal London Hospital, Barts Health NHS Trust, London, UK. christinaspyridou@gmail.com.
Ian R MorrisonDepartment of Paediatrics, The Royal London Hospital, Barts Health NHS Trust, London, UK. Ian.Morrison@bartshealth.nhs.uk.
Cheuk Y W TongDepartment of Virology, The Royal London Hospital, Barts Health NHS Trust, London, UK. william.tong@bartshealth.nhs.uk.
Andrew J PrendergastDepartment of Paediatrics, The Royal London Hospital, Barts Health NHS Trust, London, UK. a.prendergast@qmul.ac.uk.
Royal London Hospital · GBBarking, Havering And Redbridge University Hospitals NHS Trust · GBQueen Mary University of London · GB

Funding

Wellcome Trust 100714
6 · The paper itself

Abstract

backgroundRotavirus is the most common cause of severe gastroenteritis in children under the age of 5 years worldwide. It is well recognised that rotavirus can cause signs and symptoms beyond the gastrointestinal tract, including neurological manifestations such as encephalopathy. Mild encephalopathy with a reversible splenial lesion (MERS) is a clinico-radiological syndrome that has been associated with rotavirus. We report a case of a 4-year-old boy with clinically mild encephalopathy, who had an isolated splenial lesion in the corpus callosum on neuroimaging, and rotavirus RNA detected in faeces. We use this case as an opportunity to review the literature on rotavirus-associated MERS. CASE PRESENTATION: A previously healthy 4-year-old boy presented with a 2-day history of vomiting, diarrhoea, and fever, complicated by reduced level of consciousness. Magnetic resonance imaging of the brain showed a marked hyperintensity in the splenium of the corpus callosum on T2 and diffusion-weighted images. Rotavirus genome was detected by polymerase chain reaction in a stool specimen, but not in the cerebrospinal fluid. The genotype was identified as G1P8. His clinical condition improved with gradual resolution of his symptoms. No neurological complications were evident upon discharge and the patient had no recurring symptoms or significant residual defects when followed up 2 months later.

conclusionMERS is a novel clinic-radiological syndrome first described in Japan. A transient splenial lesion with reduced diffusion that appears as a high signal intensity in diffusion-weighted MRI is the main diagnostic feature. Rotavirus is one of the most common agents associated with MERS, although to our knowledge only one previous case has been reported from Europe. The majority of patients appear to achieve full recovery following rotavirus-associated MERS, irrespective of treatment. This case, together with other published reports, supports the hypothesis that rotavirus-associated MERS is unlikely to be the result of direct viral invasion of the CNS. It has been suggested that MERS may be caused by intra-myelinic axonal oedema or local inflammatory cell infiltration; however, the pathogenesis remains incompletely understood.

Indexed as

BrainBrain DiseasesCentral Nervous System InfectionsChild, PreschoolCorpus CallosumDiarrheaFecesFeverGastroenteritisHumansMagnetic Resonance ImagingMaleRadiographyRNA, ViralRotavirusRNA, Viral

Identifiers

PMID26499987
PMCPMC4619335
OpenAlexW1889301718

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.